In vivo evaluation of 68Ga-DOTA ligands shows specificity for fibroblasts, highlighting their potential applications.
Figure S11. in vivo blocking and specificity of 68Ga-DOTA-LP (A), 68Ga-DOTA-ALB-01 (B),68Ga-DOTA-ALB-02 (C), and68Ga-DOTA-ALB-03 at 1 h p.i.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: